特斯拉
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
苹果
AAPL
微软
MSFT
美股市场个股详情
APLS Apellis Pharmaceuticals
- 33.190
- +0.450+1.37%
收盘价 12/13 16:00 (美东)
- 33.190
- 0.0000.00%
盘后 20:01 (美东)
41.29亿总市值-16.35市盈率TTM
33.500最高价31.760最低价550.69万股成交量32.600今开32.740昨收1.82亿成交额6.53%换手率亏损市盈率(静)1.24亿总股本73.80052周最高17.41市净率28.00亿流通值24.34052周最低--股息TTM8435.56万流通股94.750历史最高--股息率TTM5.32%振幅11.450历史最低33.071平均价1股每手
关于Apellis Pharmaceuticals公司
Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统（免疫系统的一个组成部分）来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。
公司介绍
公司代码APLS
公司名称Apellis Pharmaceuticals
上市日期2017/11/09
发行价格14.00
成立日期2009
CEODr. Cedric Francois, M.D.
所属市场纳斯达克
员工数量706
年结日12-31
公司地址100 5th Avenue
城市Waltham
省份马萨诸塞州
国家美国
邮编02451-8703
电话1-617-977-5700
董事高管
- 姓名
- 职务
- 年薪
- Dr. Cedric Francois, M.D.
- Director, Chief Executive Officer and President
- 1037.30万
- Pascal Deschatelets, PhD
- Chief Scientific Officer
- --
- Karen Lewis
- Chief People Officer
- --
- Adam J. Townsend
- Chief Operating Officer
- 371.42万
- Nur Nicholson
- Chief Technical Operations Officer
- --
- Dr. Caroline Baumal, M.D.
- Chief Medical Officer
- 443.05万
- Timothy E. Sullivan
- Chief Financial Officer and Treasurer
- 373.72万
- James George Chopas
- Vice President, Corporate Controller and Chief Accounting Officer
- --
- Dr. Jeffrey Eisele, PhD
- Chief Development Officer
- --
- Mark Jeffrey DeLong
- Chief Business and Strategy Officer
- --
- Dr. Gerald L. Chan, Sc.D.
- Chairman of the Board
- 50.41万
- Paul Fonteyne, M.S.
- Independent Director
- 48.91万
- A. Sinclair Dunlop
- Independent Director
- 48.10万
- Alec Machiels
- Independent Director
- 49.60万
- Stephanie Monaghan O’Brien
- Independent Director
- 48.85万
- David Watson
- General Counsel
- 488.59万
